Direct determination of unbound intrinsic drug clearance in the microsomal stability assay.
The microsomal stability assay is commonly used to rank compounds according to their metabolic stability. Determination of the unbound intrinsic clearance (CL(in,u)) is essential for the accurate comparison of compounds, since nonspecific binding to microsomes can lead to an underestimation of the microsomal clearance. In this study, a new method (linear extrapolation in the stability assay, LESA) was established, which allows direct calculation of CL(in,u) from microsomal stability data, without the need to independently determine the fraction of free (unbound) drug. The method was validated using nine drugs with different chemical structures and physicochemical properties. The CL(in,u) of these compounds was extrapolated from the intrinsic clearance values obtained at different concentrations of human liver microsomes and compared with that calculated by the conventional method, using microsomal intrinsic clearance values and the free fraction of drug determined by equilibrium dialysis, ultracentrifugation, or ultrafiltration. A good agreement was observed between the data generated by the LESA method and those determined by conventional procedures. The method was further evaluated using a published dataset for 10 additional drugs and found to yield intrinsic clearance data comparable to the previously reported values. LESA provides a convenient and rapid method to determine the influence of microsome binding on intrinsic clearance in a single assay.
Giuliano
Claudio
C
Department of Pharmacology, Isituto di Ricerche di Biologia Molecolare (IRBM) P. Angletti, Merck Research Laboratories, Rome, Italy.
Jairaj
Mark
M
Zafiu
Christian M
CM
Laufer
Ralph
R
D001681:Biological Assay; D002478:Cells, Cultured; D003956:Dialysis; D006801:Humans; D008657:Metabolic Clearance Rate; D008862:Microsomes, Liver / Q000378:metabolism*; D008954:Models, Biological; D010599:Pharmacokinetics; D014461:Ultracentrifugation; D014462:Ultrafiltration